Human Complement C6 Monoclonal Antibody
| Catalog number: | B2014628 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 50 ug |
| Molecular Weight or Concentration: | N/A |
| Supplied as: | Solution |
| Applications: | molecular tool for various biochemical applications |
| Storage: | 20C |
| Keywords: | Human Complement C6 Monoclonal Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Lin K, Zhang L, Kong M, Yang M, Chen Y, Poptic E, Hoffner M, Xu J, Tam C, Lin F. Development of an anti-human complement C6 monoclonal antibody that inhibits the assembly of membrane attack complexes Blood Adv. 2020 May 12;4(9):2049-2057.
- Chaturvedi S, Brodsky RA, McCrae KR. Complement in the Pathophysiology of the Antiphospholipid Syndrome Front Immunol. 2019 Mar 14;10:449.
- Gytz Olesen H, Michailidou I, Zelek WM, Vreijling J, Ruizendaal P, de Klein F, Marquart JA, Kuipers TB, Mei H, Zhang Y, Ahasan M, Johnson KK, Wang Y, Morgan BP, van Dijk M, Fluiter K, Andersen GR, Baas F. Development, Characterization, and in vivo Validation of a Humanized C6 Monoclonal Antibody that Inhibits the Membrane Attack Complex J Innate Immun. 2022 May 12:1-21.
- Xia P, Jordon RE, Geoghegan WD. Complement fixation by pemphigus antibody. V. Assembly of the membrane attack complex on cultured human keratinocytes J Clin Invest. 1988 Dec;82(6):1939-47.
- Kusunoki Y, Takekoshi Y, Nagasawa S. Using polymerized C9 to produce a monoclonal antibody against a neoantigen of the human terminal complement complex J Pharmacobiodyn. 1990 Jul;13(7):454-60.
- Toropainen M, Saarinen L, Vidarsson G, Kyhty H. Protection by meningococcal outer membrane protein PorA-specific antibodies and a serogroup B capsular polysaccharide-specific antibody in complement-sufficient and C6-deficient infant rats Infect Immun. 2006 May;74(5):2803-8.
- Pettersen HB, Johnson E, Hetland G. Human alveolar macrophages synthesize active complement components C6, C7, and C8 in vitro Scand J Immunol. 1987 Jun;25(6):567-70.
- Huda R, Tzn E, Christadoss P. Targeting complement system to treat myasthenia gravis Rev Neurosci. 2014;25(4):575-83.
- Pytowski B, Easton TG, Valinsky JE, Calderon T, Sun T, Christman JK, Wright SD, Michl J. A monoclonal antibody to a human neutrophil-specific plasma membrane antigen. Effect of the antibody on the C3bi-mediated adherence by neutrophils and expression of the antigen during myelopoiesis J Exp Med. 1988 Feb 1;167(2):421-39.
